Late Development of Splenic Sarcoidosis-Like Lesions in a Patient With Metastatic Melanoma and Long-Lasting Clinical Response to Ipilimumab

OncoImmunology - United States
doi 10.4161/21624011.2014.954506
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Panhypopituitarism in Metastatic Melanoma Patient Treated With Ipilimumab and Pembrolizumab

Journal of Cutaneous Immunology and Allergy
2019English

Bevacizumab Plus Ipilimumab in Patients With Metastatic Melanoma

Cancer immunology research
Cancer ResearchImmunology
2014English

Scalp Melanoma Treated With Ipilimumab in Elderly Patient: A Complete Response to Treatment—Case Report

Journal of Pharmacy and Pharmacology
2017English

Corrigendum: Association of CTLA-4 Gene Variants With Response to Therapy and Long-Term Survival in Metastatic Melanoma Patients Treated With Ipilimumab: An Italian Melanoma Intergroup Study

Frontiers in Immunology
AllergyImmunology
2018English

An Abscopal Response to Radiation and Ipilimumab in a Patient With Metastatic Non-Small Cell Lung Cancer

Cancer immunology research
Cancer ResearchImmunology
2013English

Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient With Metastatic Melanoma, Psoriasis, and a Previous Guillain–Barré Syndrome

Case Reports in Oncological Medicine
Oncology
2018English

Immune Profile and Mitotic Index of Metastatic Melanoma Lesions Enhance Clinical Staging in Predicting Patient Survival

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

Severe Hemophagocytic Lymphohistiocytosis in a Melanoma Patient Treated With Ipilimumab + Nivolumab

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

Response Assessment in Metastatic Melanoma Treated With Ipilimumab and Bevacizumab: CT Tumor Size and Density as Markers for Response and Outcome

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy